Skip to Content

Biomm SA BIOM3 Stock Quote

| Rating as of


Last close prices updated as of May 29, 2023, 4:05 PM BRT | BRL
  • Last Close 5.9
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 5.80  –  6.50
  • Year Range 3.10  –  10.64
  • Market Cap 527.5580 Mil
  • Volume / Avg 166,100.0 /  23,461.3
  • Price / Sales 4.15
  • Price / Book 3.01
  • Forward Div Yield 3.47%
  • Trailing Div Yield

Morningstar‘s Stock Analysis BIOM3

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BIOM3

Company Profile BIOM3

Business Description

Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.

Praca Carlos Chagas 49 - 8th Floor, Belo Horizonte
Minas Gerais, MG, 30170020, BRA
Industry Biotechnology
Employees 127

Competitors & Peers BIOM3

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Biomm SA


Hypera SA


Milestone Pharmaceuticals Inc


Antisense Therapeutics Ltd

−$0.12 (2.93%) $0.00 (0.00%)
Market Cap
132.76 Mil40.16 Mil
Biotechnology Drug Manufacturers - Specialty & Generic Biotechnology Drug Manufacturers - Specialty & Generic

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Biomm SA Stock

No. BIOM3 does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BIOM3’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BIOM3’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BIOM3’s historical performance against its industry peers and the overall market.